Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2023

Open Access 01-12-2023 | Research

Obesity indices and the risk of total and cardiovascular mortality among people with diabetes: a long-term follow-up study in Taiwan

Authors: Chung-Yen Lu, Hsiao-Hui Chen, Kuan-Hui Chi, Pei-Chun Chen

Published in: Cardiovascular Diabetology | Issue 1/2023

Login to get access

Abstract

Background

The association between obesity indicators and mortality in individuals with diabetes remains unclear, and data on cardiovascular mortality are scarce. Therefore, we investigated the associations between the five adiposity indices and both all-cause and cardiovascular mortality in patients with diabetes.

Methods

This cohort study included 34,686 adults with diabetes who underwent a standard health-screening program between 1996 and 2017 in Taiwan. The dates and causes of death till January 2022 were retrieved from the National Death Registry. Cox proportional hazards models were used to calculate the hazard ratios (HR) and 95% confidence intervals (CI) for all-cause and cardiovascular mortality in relation to body mass index (BMI), waist circumference, waist-hip ratio (WHR), body fat percentage (BF%), and A Body Shape Index (ABSI), using the third quintile as the reference group.

Results

During a median follow-up of 15 years, there were 8,324 deaths, of which 1,748 were attributed to cardiovascular disease. After adjusting for demographics, lifestyle factors and comorbidities, ABSI was associated with all-cause mortality in an exposure-response manner; the HR (95% CI) for first and fifth vs. third quintile was 0.78 (0.69–0.89) and 1.24 (1.14–1.35), respectively. A similar but weaker exposure-response relationship was found between WHR and mortality. People with a lower BMI and BF% had an increased risk of mortality (HR [95% CI] for the first vs. third quintiles, 1.33 [1.22, 1.44] and 1.42 [1.30, 1.56], respectively). No association was observed between waist circumference categories and risk of mortality. Similar results were observed for the association of BF%, waist circumference, and ABSI with cardiovascular mortality. However, no significant association was observed between BMI and cardiovascular mortality. The association between WHR and cardiovascular mortality was stronger than that between WHR and all-cause mortality.

Conclusions

ABSI demonstrated a consistent exposure-response relationship with both all-cause and cardiovascular mortality in this Asian cohort with diabetes. Our findings highlight the importance of monitoring ABSI, a surrogate index of central adiposity, in patients with diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Global regional, national burden of diabetes. and From 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of Disease Study 2021. Lancet. 2023. Global regional, national burden of diabetes. and From 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of Disease Study 2021. Lancet. 2023.
3.
go back to reference An Y, Zhang P, Wang J, Gong Q, Gregg EW, Yang W, Li H, Zhang B, Shuai Y, Chen Y, et al. Cardiovascular and all-cause Mortality over a 23-Year period among Chinese with newly diagnosed Diabetes in the Da Qing IGT and Diabetes Study. Diabetes Care. 2015;38:1365–71.CrossRefPubMedPubMedCentral An Y, Zhang P, Wang J, Gong Q, Gregg EW, Yang W, Li H, Zhang B, Shuai Y, Chen Y, et al. Cardiovascular and all-cause Mortality over a 23-Year period among Chinese with newly diagnosed Diabetes in the Da Qing IGT and Diabetes Study. Diabetes Care. 2015;38:1365–71.CrossRefPubMedPubMedCentral
4.
go back to reference Tancredi M, Rosengren A, Svensson AM, Kosiborod M, Pivodic A, Gudbjörnsdottir S, Wedel H, Clements M, Dahlqvist S, Lind M. Excess mortality among persons with type 2 Diabetes. N Engl J Med. 2015;373:1720–32.CrossRefPubMed Tancredi M, Rosengren A, Svensson AM, Kosiborod M, Pivodic A, Gudbjörnsdottir S, Wedel H, Clements M, Dahlqvist S, Lind M. Excess mortality among persons with type 2 Diabetes. N Engl J Med. 2015;373:1720–32.CrossRefPubMed
5.
go back to reference Zaccardi F, Dhalwani NN, Papamargaritis D, Webb DR, Murphy GJ, Davies MJ, Khunti K. Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 Diabetes Mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies. Diabetologia. 2017;60:240–8.CrossRefPubMed Zaccardi F, Dhalwani NN, Papamargaritis D, Webb DR, Murphy GJ, Davies MJ, Khunti K. Nonlinear association of BMI with all-cause and cardiovascular mortality in type 2 Diabetes Mellitus: a systematic review and meta-analysis of 414,587 participants in prospective studies. Diabetologia. 2017;60:240–8.CrossRefPubMed
6.
go back to reference Tate J, Knuiman M, Davis WA, Davis TME, Bruce DG. A comparison of obesity indices in relation to mortality in type 2 Diabetes: the Fremantle Diabetes Study. Diabetologia. 2020;63:528–36.CrossRefPubMed Tate J, Knuiman M, Davis WA, Davis TME, Bruce DG. A comparison of obesity indices in relation to mortality in type 2 Diabetes: the Fremantle Diabetes Study. Diabetologia. 2020;63:528–36.CrossRefPubMed
7.
go back to reference Dulloo AG, Jacquet J, Solinas G, Montani JP, Schutz Y. Body composition phenotypes in pathways to obesity and the metabolic syndrome. Int J Obes (Lond). 2010;34(Suppl 2):4–17.CrossRef Dulloo AG, Jacquet J, Solinas G, Montani JP, Schutz Y. Body composition phenotypes in pathways to obesity and the metabolic syndrome. Int J Obes (Lond). 2010;34(Suppl 2):4–17.CrossRef
8.
go back to reference Sahakyan KR, Somers VK, Rodriguez-Escudero JP, Hodge DO, Carter RE, Sochor O, Coutinho T, Jensen MD, Roger VL, Singh P, et al. Normal-weight central obesity: implications for Total and Cardiovascular Mortality. Ann Intern Med. 2015;163:827–35.CrossRefPubMedPubMedCentral Sahakyan KR, Somers VK, Rodriguez-Escudero JP, Hodge DO, Carter RE, Sochor O, Coutinho T, Jensen MD, Roger VL, Singh P, et al. Normal-weight central obesity: implications for Total and Cardiovascular Mortality. Ann Intern Med. 2015;163:827–35.CrossRefPubMedPubMedCentral
9.
go back to reference Sun Y, Liu B, Snetselaar LG, Wallace RB, Caan BJ, Rohan TE, Neuhouser ML, Shadyab AH, Chlebowski RT, Manson JE, et al. Association of Normal-Weight Central Obesity with all-cause and cause-Specific Mortality among Postmenopausal Women. JAMA Netw Open. 2019;2:e197337.CrossRefPubMedPubMedCentral Sun Y, Liu B, Snetselaar LG, Wallace RB, Caan BJ, Rohan TE, Neuhouser ML, Shadyab AH, Chlebowski RT, Manson JE, et al. Association of Normal-Weight Central Obesity with all-cause and cause-Specific Mortality among Postmenopausal Women. JAMA Netw Open. 2019;2:e197337.CrossRefPubMedPubMedCentral
10.
go back to reference Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation. 2008;117:1658–67.CrossRefPubMed Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation. 2008;117:1658–67.CrossRefPubMed
12.
go back to reference Ji M, Zhang S, An R. Effectiveness of a body shape index (ABSI) in predicting chronic Diseases and mortality: a systematic review and meta-analysis. Obes Rev. 2018;19:737–59.CrossRefPubMed Ji M, Zhang S, An R. Effectiveness of a body shape index (ABSI) in predicting chronic Diseases and mortality: a systematic review and meta-analysis. Obes Rev. 2018;19:737–59.CrossRefPubMed
13.
go back to reference Lee DY, Lee MY, Sung KC. Prediction of mortality with a body shape index in Young asians: comparison with body Mass Index and Waist circumference. Obes (Silver Spring). 2018;26:1096–103.CrossRef Lee DY, Lee MY, Sung KC. Prediction of mortality with a body shape index in Young asians: comparison with body Mass Index and Waist circumference. Obes (Silver Spring). 2018;26:1096–103.CrossRef
14.
go back to reference Orsi E, Solini A, Penno G, Bonora E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Lamacchia O, Haxhi J, et al. Body mass index versus surrogate measures of central adiposity as Independent predictors of mortality in type 2 Diabetes. Cardiovasc Diabetol. 2022;21:266.CrossRefPubMedPubMedCentral Orsi E, Solini A, Penno G, Bonora E, Fondelli C, Trevisan R, Vedovato M, Cavalot F, Lamacchia O, Haxhi J, et al. Body mass index versus surrogate measures of central adiposity as Independent predictors of mortality in type 2 Diabetes. Cardiovasc Diabetol. 2022;21:266.CrossRefPubMedPubMedCentral
16.
go back to reference Wu X, Tsai SP, Tsao CK, Chiu ML, Tsai MK, Lu PJ, Lee JH, Chen CH, Wen C, Chang SS, et al. Cohort Profile: the Taiwan MJ Cohort: half a million Chinese with repeated health surveillance data. Int J Epidemiol. 2017;46:1744–1744 g.CrossRefPubMed Wu X, Tsai SP, Tsao CK, Chiu ML, Tsai MK, Lu PJ, Lee JH, Chen CH, Wen C, Chang SS, et al. Cohort Profile: the Taiwan MJ Cohort: half a million Chinese with repeated health surveillance data. Int J Epidemiol. 2017;46:1744–1744 g.CrossRefPubMed
17.
go back to reference Committee ADAPP. 2. Classification and diagnosis of Diabetes: standards of Medical Care in Diabetes—2022. Diabetes Care. 2021;45:17–S38. Committee ADAPP. 2. Classification and diagnosis of Diabetes: standards of Medical Care in Diabetes—2022. Diabetes Care. 2021;45:17–S38.
18.
go back to reference Chang SS, Wen CP, Tsai MK, Lawlor DA, Yang YC, Gunnell D. Adiposity, its related biologic risk factors, and Suicide: a cohort study of 542,088 Taiwanese adults. Am J Epidemiol. 2012;175:804–15.CrossRefPubMed Chang SS, Wen CP, Tsai MK, Lawlor DA, Yang YC, Gunnell D. Adiposity, its related biologic risk factors, and Suicide: a cohort study of 542,088 Taiwanese adults. Am J Epidemiol. 2012;175:804–15.CrossRefPubMed
19.
go back to reference Yu T, Bo Y, Chang L-y, Liu X, Tam T, Lao XQ. Adiposity and risk of death: a prospective cohort study of 463,002 adults. Clin Nutr. 2021;40:1932–41.CrossRefPubMed Yu T, Bo Y, Chang L-y, Liu X, Tam T, Lao XQ. Adiposity and risk of death: a prospective cohort study of 463,002 adults. Clin Nutr. 2021;40:1932–41.CrossRefPubMed
20.
go back to reference Hayes LD, Sculthorpe N, Herbert P, Baker JS, Spagna R, Grace FM. Six weeks of conditioning exercise increases total, but not free testosterone in lifelong sedentary aging men. Aging Male. 2015;18:195–200.CrossRefPubMed Hayes LD, Sculthorpe N, Herbert P, Baker JS, Spagna R, Grace FM. Six weeks of conditioning exercise increases total, but not free testosterone in lifelong sedentary aging men. Aging Male. 2015;18:195–200.CrossRefPubMed
21.
go back to reference Jebb SA, Cole TJ, Doman D, Murgatroyd PR, Prentice AM. Evaluation of the novel Tanita body-fat analyser to measure body composition by comparison with a four-compartment model. Br J Nutr. 2000;83:115–22.CrossRefPubMed Jebb SA, Cole TJ, Doman D, Murgatroyd PR, Prentice AM. Evaluation of the novel Tanita body-fat analyser to measure body composition by comparison with a four-compartment model. Br J Nutr. 2000;83:115–22.CrossRefPubMed
22.
go back to reference Abe T, Kearns CF, Fukunaga T. Sex differences in whole body skeletal muscle mass measured by magnetic resonance imaging and its distribution in young Japanese adults. Br J Sports Med. 2003;37:436–40.CrossRefPubMedPubMedCentral Abe T, Kearns CF, Fukunaga T. Sex differences in whole body skeletal muscle mass measured by magnetic resonance imaging and its distribution in young Japanese adults. Br J Sports Med. 2003;37:436–40.CrossRefPubMedPubMedCentral
23.
24.
go back to reference Brozek J, Grande F, Anderson JT, Keys A. Densitometric analysis of body composition: revision of some quantitative assumptions. Ann N Y Acad Sci. 1963;110:113–40.CrossRefPubMed Brozek J, Grande F, Anderson JT, Keys A. Densitometric analysis of body composition: revision of some quantitative assumptions. Ann N Y Acad Sci. 1963;110:113–40.CrossRefPubMed
25.
go back to reference Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, et al. Obesity and Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation. 2021;143:e984–e1010.CrossRefPubMedPubMedCentral Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, Lear SA, Ndumele CE, Neeland IJ, Sanders P, et al. Obesity and Cardiovascular Disease: A Scientific Statement from the American Heart Association. Circulation. 2021;143:e984–e1010.CrossRefPubMedPubMedCentral
26.
go back to reference Hughes RA, Heron J, Sterne JAC, Tilling K. Accounting for missing data in statistical analyses: multiple imputation is not always the answer. Int J Epidemiol. 2019;48:1294–304.CrossRefPubMedPubMedCentral Hughes RA, Heron J, Sterne JAC, Tilling K. Accounting for missing data in statistical analyses: multiple imputation is not always the answer. Int J Epidemiol. 2019;48:1294–304.CrossRefPubMedPubMedCentral
27.
go back to reference Elze MC, Gregson J, Baber U, Williamson E, Sartori S, Mehran R, Nichols M, Stone GW, Pocock SJ. Comparison of Propensity score methods and Covariate Adjustment: evaluation in 4 Cardiovascular studies. J Am Coll Cardiol. 2017;69:345–57.CrossRefPubMed Elze MC, Gregson J, Baber U, Williamson E, Sartori S, Mehran R, Nichols M, Stone GW, Pocock SJ. Comparison of Propensity score methods and Covariate Adjustment: evaluation in 4 Cardiovascular studies. J Am Coll Cardiol. 2017;69:345–57.CrossRefPubMed
28.
go back to reference Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med. 2009;150:795–802.CrossRefPubMedPubMedCentral Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med. 2009;150:795–802.CrossRefPubMedPubMedCentral
29.
go back to reference Sun X, Cao L, Liu Y, Huang W, Pei C, Wang X, Feng S, Song B. Sex- and age-specific differences in associations of a body shape index with all-cause and cardiovascular death risks among US adults with Diabetes. Nutr Metab Cardiovasc Dis. 2023;33:551–9.CrossRefPubMed Sun X, Cao L, Liu Y, Huang W, Pei C, Wang X, Feng S, Song B. Sex- and age-specific differences in associations of a body shape index with all-cause and cardiovascular death risks among US adults with Diabetes. Nutr Metab Cardiovasc Dis. 2023;33:551–9.CrossRefPubMed
30.
go back to reference Carnethon MR, Rasmussen-Torvik LJ, Palaniappan L. The obesity Paradox in Diabetes. Curr Cardiol Rep 2014; 16. Carnethon MR, Rasmussen-Torvik LJ, Palaniappan L. The obesity Paradox in Diabetes. Curr Cardiol Rep 2014; 16.
31.
go back to reference Ades PA, Savage PD. The obesity paradox: perception vs knowledge. Mayo Clin Proc 2010; 85:112–114. Ades PA, Savage PD. The obesity paradox: perception vs knowledge. Mayo Clin Proc 2010; 85:112–114.
32.
go back to reference Banack HR, Stokes A. The ‘obesity paradox’ may not be a paradox at all. Int J Obes (Lond). 2017;41:1162–3.CrossRefPubMed Banack HR, Stokes A. The ‘obesity paradox’ may not be a paradox at all. Int J Obes (Lond). 2017;41:1162–3.CrossRefPubMed
33.
go back to reference Finelli C, Sommella L, Gioia S, La Sala N, Tarantino G. Should visceral fat be reduced to increase longevity? Ageing Res Rev. 2013;12:996–1004.CrossRefPubMed Finelli C, Sommella L, Gioia S, La Sala N, Tarantino G. Should visceral fat be reduced to increase longevity? Ageing Res Rev. 2013;12:996–1004.CrossRefPubMed
34.
go back to reference Jayedi A, Khan TA, Aune D, Emadi A, Shab-Bidar S. Body fat and risk of all-cause mortality: a systematic review and dose-response meta-analysis of prospective cohort studies. Int J Obes (Lond). 2022;46:1573–81.CrossRefPubMed Jayedi A, Khan TA, Aune D, Emadi A, Shab-Bidar S. Body fat and risk of all-cause mortality: a systematic review and dose-response meta-analysis of prospective cohort studies. Int J Obes (Lond). 2022;46:1573–81.CrossRefPubMed
35.
go back to reference Ritz P, Salle A, Audran M, Rohmer V. Comparison of different methods to assess body composition of weight loss in obese and diabetic patients. Diabetes Res Clin Pract. 2007;77:405–11.CrossRefPubMed Ritz P, Salle A, Audran M, Rohmer V. Comparison of different methods to assess body composition of weight loss in obese and diabetic patients. Diabetes Res Clin Pract. 2007;77:405–11.CrossRefPubMed
36.
go back to reference Brizzolara A, Barbieri MP, Adezati L, Viviani GL. Water distribution in insulin-dependent Diabetes Mellitus in various states of metabolic control. Eur J Endocrinol. 1996;135:609–15.CrossRefPubMed Brizzolara A, Barbieri MP, Adezati L, Viviani GL. Water distribution in insulin-dependent Diabetes Mellitus in various states of metabolic control. Eur J Endocrinol. 1996;135:609–15.CrossRefPubMed
37.
go back to reference Tsui EY, Gao XJ, Zinman B. Bioelectrical impedance analysis (BIA) using bipolar foot electrodes in the assessment of body composition in type 2 Diabetes Mellitus. Diabet Med. 1998;15:125–8.CrossRefPubMed Tsui EY, Gao XJ, Zinman B. Bioelectrical impedance analysis (BIA) using bipolar foot electrodes in the assessment of body composition in type 2 Diabetes Mellitus. Diabet Med. 1998;15:125–8.CrossRefPubMed
38.
go back to reference Miyatani M, Yang P, Thomas S, Craven BC, Oh P. Bioelectrical Impedance and Dual-Energy X-Ray Absorptiometry Assessments of Changes in Body Composition Following Exercise in Patients with Type 2 Diabetes Mellitus. Journal of Obesity 2012; 2012:1–9. Miyatani M, Yang P, Thomas S, Craven BC, Oh P. Bioelectrical Impedance and Dual-Energy X-Ray Absorptiometry Assessments of Changes in Body Composition Following Exercise in Patients with Type 2 Diabetes Mellitus. Journal of Obesity 2012; 2012:1–9.
39.
go back to reference Kim S, Jeong JC, Ahn SY, Doh K, Jin DC, Na KY. Time-varying effects of body mass index on mortality among hemodialysis patients: results from a nationwide Korean registry. Kidney Res Clin Pract. 2019;38:90–9.CrossRefPubMedPubMedCentral Kim S, Jeong JC, Ahn SY, Doh K, Jin DC, Na KY. Time-varying effects of body mass index on mortality among hemodialysis patients: results from a nationwide Korean registry. Kidney Res Clin Pract. 2019;38:90–9.CrossRefPubMedPubMedCentral
40.
go back to reference Zhu J, Liu X, Zhang J, Li J, Chen L, Huang C, Li J, Yu Y, Xu H, Qin G. Time-varying association between body mass index and all-cause mortality in patients with Hypertension. Int J Obes (Lond). 2022;46:316–24.CrossRefPubMed Zhu J, Liu X, Zhang J, Li J, Chen L, Huang C, Li J, Yu Y, Xu H, Qin G. Time-varying association between body mass index and all-cause mortality in patients with Hypertension. Int J Obes (Lond). 2022;46:316–24.CrossRefPubMed
41.
go back to reference Sheen YJ, Hsu CC, Jiang YD, Huang CN, Liu JS, Sheu WH. Trends in prevalence and incidence of Diabetes Mellitus from 2005 to 2014 in Taiwan. J Formos Med Assoc. 2019;118(Suppl 2):66–s73.CrossRef Sheen YJ, Hsu CC, Jiang YD, Huang CN, Liu JS, Sheu WH. Trends in prevalence and incidence of Diabetes Mellitus from 2005 to 2014 in Taiwan. J Formos Med Assoc. 2019;118(Suppl 2):66–s73.CrossRef
Metadata
Title
Obesity indices and the risk of total and cardiovascular mortality among people with diabetes: a long-term follow-up study in Taiwan
Authors
Chung-Yen Lu
Hsiao-Hui Chen
Kuan-Hui Chi
Pei-Chun Chen
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2023
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-023-02072-3

Other articles of this Issue 1/2023

Cardiovascular Diabetology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine